Incorrect Data in Abstract and Figure

No authors listed

Published Erratum

No authors listed. JAMA. 2023.

. 2023 Mar 28;329(12):1034.

doi: 10.1001/jama.2023.3272.

No abstract available

Erratum for

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.

1. Maturi RK, Glassman AR, Josic K, et al. ; DRCR Retina Network . Four-year visual outcomes in the Protocol W randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathy. JAMA. 2023;329(5):376-385. doi:10.1001/jama.2022.25029 - DOI - PMC - PubMed